Comprehensive Insight on the Scleroderma Drug Pipeline Landscape Revealed in the Latest 2024 Report
22 nov. 2024 06h56 HE
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Scleroderma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The Scleroderma drug pipeline report for 2024 has...
Scleroderma Diagnostics and Therapeutics Market Report 2024-2030: Rising Adoption of Immunosuppressive Drugs Bodes Well for Growth
01 nov. 2024 05h14 HE
|
Research and Markets
Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Scleroderma Diagnostics and Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Global Systemic Sclerosis (Scleroderma) Clinical Trials Review 2024: Clinical Trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
31 mai 2024 04h34 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
Scleroderma Therapeutics Market Garner US$ 3.8 Bn by 2026
17 juil. 2019 12h00 HE
|
Acumen Research and Consulting
LOS ANGELES, July 17, 2019 (GLOBE NEWSWIRE) -- The global scleroderma therapeutics market is estimated to grow at CAGR above 6.4% over the forecast time frame and reach the market value around US$...